ππ¬π¬πππ² ππππππ πππππππ
@perilonthesea
Advocating progress on #pancreascancer, #BRCA, carer support. Partner survived #PDAC 8+ yrs; treated at MSK. Law (JD);ππΌscience, & the sea. #pancreaticcancer
ID:2497852175
20-04-2014 18:47:26
4,4K Tweets
757 Followers
797 Following
With the successful Henry Ford Health Pancreatic Cancer Center Symposium in the books, I want to take a second to share the takeaways online.
On #HCC #FLC #germline #globalaccess juan carlos salas and more in an interview with Memorial Sloan Kettering Cancer Center MSK Department of Medicine American University of Beirut via Encyclopedia MDPI encyclopedia.pub/video/video_deβ¦
I will be speaking on #Treatment Updates and #clinicaltrials for #PancreaticCancer in an webinar for patients and family members in honor for Pancreatic Cancer Awareness month. We have a great program lined up! Dr. Allyson Ocean National Pancreas Foundation Let's Win Pancreatic Cancer π WCM GI Cancer PanCAN AACR
looking forward to the Henry ford Pancreatic Cancer Conference this Friday. It's never too late to join Jash Datta Syed A. Ahmad Douglas B. Evans Ching-Wei D. Tzeng Matthew HG Katz, MD Monica-Amit Mishra PanCAN Michigan #PanCanMatters
Join us for a webinar discussing the latest on #PancreaticCancer 11/7 at 6pmEST with Dr. Despina Siolas, MD, PhD Reem Sharaiha, MD MS Francesca Tubito-Massarano and more! Patients will also be a part of this important event during #pancreaticcancerawarenessmonth Use the QR code to register. ποΈ you there! ππ
From the October issue: #Singlecell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in #PancreaticCancer , by Michael Kim, Nicholas Navin, Chantale Bernatchez et al.
bit.ly/3sbwURF
MD Anderson Cancer Center
π₯FGFR2 fusion in metastatic pancreatic ductal adenocarcinoma: Is there hope? π₯
ejcancer.com/article/S0959-β¦
β
4 intersting cases responding to FGFRi
πall KRAS WT with comparable long survival
π§non-typical fusion partners
π―Early NGS in KRAS WT #PDAC βοΈ
ESMO - Eur. Oncology OncoAlert
More evidence that germline ATM mutations with low HRD scores are not candidates for PARP inhibitor monotherapy. No responses here in both #PancreaticCancer cases.